Wednesday, September 18, 2024

eXeX Secures $5.8M Seed Funding, Welcomes Michael Dykier as CTO

Related stories

Genpact Named Leader in 2024 Life Sciences Digital Services

Recognition highlights Genpact's commitment to delivering personalized support and innovative...

Adobe Experience Cloud Enhances AI Content Personalization

Adobe Content Analytics unlocks the ability for brands to...

SentinelOne & Lenovo Partner for AI Security in PCs

Multi-year deal will bring SentinelOne’s Singularity Platform and Purple...

Verint AI Bots Boost Upsell and Revenue in Contact Centers

Verint, The CX Automation Company™, announced that contact centers...

Debiopharm & WhiteLab Partner to Advance Oncology Drug Design

Debiopharm finalizes a strategic partnership to leverage WhiteLab’s proprietary...
spot_imgspot_img

eXeX, a pioneering med tech company utilizing artificial intelligence and spatial computing to optimize surgical procedures, announced the successful closing of a $5.8 million priced seed round. This milestone comes just two years after the company’s inception and marks a significant step forward in its mission to enhance surgical healthcare globally.

Founded in 2022, eXeX has built a revolutionary platform that allows surgical teams to onboard staff and complete surgical procedures with increased efficiency and accuracy. The company has patented its technology, which has been utilized in over 2,000 live surgeries across three continents, yielding incredible results.

“We are grateful for our investment partners and alpha sites for their participation and brilliant insights that have contributed to our purposeful evolution forward, hitting every milestone to date,” said Dr. Robert Masson, CEO of eXeX.

Also Read: Qventus Launches AI Operational Assistants to Reduce Administrative Burden and Enhance Patient Care

In addition to the funding milestone, eXeX is pleased to announce the appointment of Michael Dykier as Chief Technology Officer (CTO). Michael joins eXeX from DAS Labs, where he was the founder and a pioneer in mixed reality-based software development. He brings extensive experience with artificial intelligence and immersive technology to the team.

“I am excited to join eXeX at such a pivotal time,” said Michael Dykier. “The company’s innovative approach to integrating AI and spatial computing in surgical procedures is truly groundbreaking. I look forward to contributing to the next phase of development and ensuring our technology transforms surgical practices worldwide.”

The funds raised in this seed round will be used to accelerate the development of the platform and support its upcoming commercial debut. eXeX is set to launch commercially in early 2025, with initial availability at select hospitals across the United States and United Kingdom.

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img